{"id":"NCT00637195","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety of a Commercially Available Vaccine Co-administered With GSK HPV Vaccine (580299)","officialTitle":"Evaluation of the Immunogenicity and Safety of a Commercially Available Vaccine When Co-administered With GlaxoSmithKline Biologicals' HPV Vaccine (580299) in Healthy Female Subjects.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-03-11","primaryCompletion":"2008-06-20","completion":"2009-06-18","firstPosted":"2008-03-17","resultsPosted":"2009-12-18","lastUpdate":"2020-01-03"},"enrollment":152,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Papillomavirus","Papillomavirus Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"Subjects received 3 doses of GSK Biologicals' HPV vaccine (580299) (Cervarix™)","otherNames":["GSK Biologicals' HPV vaccine 580299"]},{"type":"BIOLOGICAL","name":"Engerix™","otherNames":["GSK Biologicals' vaccine 103860"]}],"arms":[{"label":"Cervarix™ & Engerix™ Group","type":"EXPERIMENTAL"},{"label":"Engerix™ Group","type":"ACTIVE_COMPARATOR"}],"summary":"Infection with human papillomavirus (HPV) has been clearly established as the necessary cause of cervical cancer. The current Phase 3b study is designed to assess the immunogenicity and safety of a commercially available vaccine co-administered with GlaxoSmithKline Biologicals' HPV vaccine GSK580299 in healthy female subjects.","primaryOutcome":{"measure":"Number of Subjects Seroprotected Against Hepatitis B Following 3 Doses of Engerix","timeFrame":"Month 3","effectByArm":[{"arm":"Cervarix™ & Engerix™ Group","deltaMin":70,"sd":null},{"arm":"Engerix™ Group","deltaMin":73,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":2,"countries":["Belgium"]},"refs":{"pmids":["21734063"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":76},"commonTop":["Pain at injection site","Fatigue","Headache","Myalgia","Gastrointestinal symptom"]}}